Home
>
National Drug Code (NDC)
>
ANASCORP
ANASCORP - 66621-0150-1 - (CENTRUROIDES (Scorpion) IMMUNE F(ab)2 (EQUINE))
Drug Information of ANASCORP
| Product NDC: | 66621-0150 |
| Proprietary Name: | ANASCORP |
| Non Proprietary Name: | CENTRUROIDES (Scorpion) IMMUNE F(ab)2 (EQUINE) |
| Active Ingredient(s): | 24 mg/mL & nbsp; CENTRUROIDES (Scorpion) IMMUNE F(ab)2 (EQUINE) |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ANASCORP
| Product NDC: | 66621-0150 |
| Labeler Name: | Rare Disease Therapeutics, Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA125335 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20110803 |
Package Information of ANASCORP
| Package NDC: | 66621-0150-1 |
| Package Description: | 1 VIAL in 1 CARTON (66621-0150-1) > 10 mL in 1 VIAL |
NDC Information of ANASCORP
| NDC Code | 66621-0150-1 |
| Proprietary Name | ANASCORP |
| Package Description | 1 VIAL in 1 CARTON (66621-0150-1) > 10 mL in 1 VIAL |
| Product NDC | 66621-0150 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | CENTRUROIDES (Scorpion) IMMUNE F(ab)2 (EQUINE) |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20110803 |
| Marketing Category Name | BLA |
| Labeler Name | Rare Disease Therapeutics, Inc |
| Substance Name | CENTRUROIDES FAB2 ANTIVENIN (EQUINE) |
| Strength Number | 24 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Antivenin [EPC],Passively Acquired Immunity [PE],Venom Neutralization [MoA],Antivenins [Chemical/Ingredient] |
